bioRxivImmunologyPreprint
Type I IFN dynamics define an early checkpoint for survival and orchestrate systemic neutrophil heterogeneity in lethal viral infection
Riho Saito, Akisawa SatomiiD, Hiroki SugishitaiD, Yukiko GotohiD, Tomohiko OkazakiiD
Abstract
The early host response is critical for protection against viral infections, yet the systemic events that dictate individual differences in outcomes remain poorly defined. Here, we leveraged variability in survival following intranasal vesicular stomatitis virus (VSV) challenge in genetically identical mice to retrospectively profile systemic immune responses associated with survival or lethality. Survival was strongly associated with a robust systemic type I interferon (IFN) surge within 24 hours of infection, and blockade of type I IFN signaling during this narrow early window markedly reduced survival, establishing early IFN induction as a key determinant of outcome. This protective IFN surge rapidly remodeled the systemic immune landscape. Single-cell profiling revealed a transcriptionally and functionally distinct ICAM1 neutrophil subset as the strongest early correlate of survival, primed within the bone marrow. ICAM1 neutrophils exhibited a pro-inflammatory signature and enhanced phagocytic activity compared with ICAM1- neutrophils, which predominated in lethal outcomes. Together, these findings define a type I IFN-driven early checkpoint that governs survival in lethal viral infection and identify ICAM1 neutrophils as a blood-accessible biomarker of protective immunity, highlighting the critical role of early innate immune dynamics in shaping disease trajectories and providing a framework for early prognostic markers and host-directed therapies.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden
N. J. Parekh, T. E. Krouse, … C. C. Norbury·bioRxiv·May 2, 2019
- IFN-κ directs antiviral immunity in human skin
Jafira M. Johnson, Laurellee Payne, … Megan H. Orzalli·bioRxiv·Sep 23, 2026
- Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection
Benjamin J. Broomfield, Chin Wee Tan, … Joanna R. Groom·The Journal of Experimental MedicinePeer-reviewed·Feb 5, 2025
- Type I IFN promotes pathogenic inflammatory monocyte maturation during H5N1 infection
S. Fourati, D. Jimenez-Morales, … M. B. Uccellini·bioRxiv·Jan 10, 2022
- A sustained type I IFN-neutrophil-IL-18 axis drives pathology during mucosal viral infection
T. Lebratti, Y. S. Lim, … H. Shin·bioRxiv·Dec 20, 2020
- Type I IFN stimulates lymph node stromal cells from adult and old mice during a West Nile virus infection
A. K. Bennett, M. Richner, … J. M. Richner·bioRxiv·Jan 5, 2023